Back to search
FDAFDA · Food and drugs·Recall number D-0833-2020

Lamotrigine Tablets, USP, 100 mg, Rx Only, 100-count bottle, Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4131-1.

Published February 19, 2020 · Recall initiated: December 20, 2019

Summary

FDA records drug Class I recall D-0833-2020, published February 19, 2020 and initiated December 20, 2019. Recalling firm: Taro Pharmaceuticals U.S.A., Inc.; Status: Terminated; Lot: Lot #: 331771, Exp. June 2021. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate.

What to do

Voluntary: Firm initiated · Letter

Get an email if LAMOTRIGINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LAMOTRIGINE
Manufacturer
Taro Pharmaceuticals U.S.A., Inc.
Distributor
Nationwide in the U.S. and Puerto Rico.
UPC
0351672413019
Lot
Lot #: 331771, Exp. June 2021
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lamotrigine Tablets, USP, 100 mg, Rx Only, 100-count bottle, Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4131-1. recalled?

Yes. FDA published recall D-0833-2020 on February 19, 2020. Reported hazard: Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LAMOTRIGINE. UPC: 0351672413019.